PW
BIO icon

Price Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History

Price Wealth’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$12K Buy
+24
New +$12.2K ﹤0.01% 262

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Price Wealth's BIO Position: Q3 2020 in Review

Price Wealth opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2020: 24 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #262 among its holdings.

478 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • Price Wealth held 24 shares of Bio-Rad Laboratories Class A worth $12K as of Q3 2020.
  • Bio-Rad Laboratories Class A was a new Price Wealth position in Q3 2020.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Price Wealth's portfolio in Q3 2020, its #262 holding.
  • 478 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.